Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy.
Arthritis Rheumatol
; 74(8): 1321-1332, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35507355
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Viral Vaccines
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Arthritis Rheumatol
Year:
2022
Type:
Article
Affiliation country:
Norway